Lithium Tapering Schedule for 150 mg Daily Dose
For a patient taking lithium 150 mg daily, the recommended tapering schedule is a 10% reduction of the original dose per month with monthly follow-up visits. 1
Tapering Schedule for Lithium 150 mg Daily
Initial Approach
- Begin with a 10% reduction of the original dose (15 mg) per month
- Month 1: Reduce to 135 mg daily
- Month 2: Reduce to 120 mg daily
- Month 3: Reduce to 105 mg daily
- Month 4: Reduce to 90 mg daily
- Month 5: Reduce to 75 mg daily
- Month 6: Reduce to 60 mg daily
- Month 7: Reduce to 45 mg daily
- Month 8: Reduce to 30 mg daily
- Final phase: Consider alternate day dosing before complete discontinuation
Monitoring and Follow-up
- Schedule monthly follow-up visits during the tapering process
- If withdrawal symptoms emerge, increase frequency to every 2 weeks 1
- Monitor for:
- Sleep disturbances
- Mood changes or instability
- Anxiety
- Headache
- Dizziness
Adjusting the Taper
- If withdrawal symptoms emerge:
- Pause the taper at the current dose for 1-2 weeks until symptoms stabilize
- Resume tapering at a slower rate (5% reduction instead of 10%) 1
- For patients who have been on lithium for longer periods (>1 year), consider an even slower taper of 5% per month
Special Considerations
Patient-Specific Factors
- Age: Elderly patients may require a more gradual tapering schedule (5% reduction every 2 weeks) 1
- Duration of use: Longer duration of lithium use warrants slower tapering
- Medical comorbidities:
Potential Withdrawal Symptoms
- Lithium discontinuation can lead to:
- Mood instability or recurrence of bipolar symptoms
- Anxiety
- Sleep disturbances
- Irritability
Managing Withdrawal Symptoms
- Non-pharmacological approaches:
- Cognitive behavioral therapy
- Regular exercise
- Sleep hygiene practices
- Stress management techniques 1
Cautions and Pitfalls
- Avoid abrupt discontinuation: This can lead to withdrawal symptoms and increased risk of relapse 2
- Monitor for bipolar relapse: Tapering lithium increases risk of mood episode recurrence
- Laboratory monitoring: Continue to monitor renal function, thyroid function, and electrolytes during the tapering process 3
- Therapeutic alliance: Maintain clear communication with the patient about the tapering plan and potential symptoms to report
Evidence Quality
The evidence for lithium tapering specifically is limited, but the recommended approach follows established principles for medication tapering. The American Academy of Sleep Medicine and CDC guidelines support the 10% reduction per month approach for medication tapering 1, which can be applied to lithium discontinuation. The evidence clearly shows that tapering is superior to abrupt discontinuation in reducing discontinuation symptoms 2.